FTC eyes resuming insulin lawsuit against drug middlemen
The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...
FTC Puts Hold on Insulin Lawsuit Against Drug Middlemen
The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...
The Lund Report1 天
Did Trump tank the FTC’s insulin suit? Observers want to know
The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...
STAT2 天
FTC suit over PBMs’ insulin pricing is delayed in part by Trump firings
A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...
Reuters2 天
FTC puts hold on insulin lawsuit against drug middlemen
The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes patients towards higher priced insulin in order to reap millions of ...
FTC’s Case Against Drug Managers on Hold After Commissioners Fired
The agency has paused its lawsuit against three pharmacy-benefit managers because no current commissioners can participate in ...
Ferguson Joins, Restarts FTC Case Targeting PBMs Over Insulin Pricing
The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...
Is Ozempic a game-changer for insulin resistance? What you need to know
SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.
Yahoo2 天
FTC puts hold on insulin lawsuit against drug middlemen
FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York ...